Aclarion Stock (NASDAQ:ACON)

Revenue Ownership Financials Chart

Previous Close

$3.26

52W Range

$2.34 - $12.03

50D Avg

$3.32

200D Avg

$5.09

Market Cap

$1.69M

Avg Vol (3M)

$97.55K

Beta

1.22

Div Yield

ACON Company Profile

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Apr 22, 2022

Website

ACON Performance

ACON Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$75.73B	$45.72K	$75.40K
Operating Income	$-7.05T	$-5.51M	$-4.88M
Net Income	$-7.23T	$-6.99M	$-4.91M
EBITDA	$-7.05T	$-6.26M	$-4.14M
Basic EPS	$-13.61	$-7.48K	$-79.78K
Diluted EPS	$-13.61	$-7.48K	$-79.78K

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
MSPR	MSP Recovery, Inc.
BNBX	BNB Plus Corp.
SNGX	Soligenix, Inc.
KZIA	Kazia Therapeutics Limited
BFRG	Bullfrog AI Holdings, Inc. Common Stock
TTNP	Titan Pharmaceuticals, Inc.
SILO	Silo Pharma, Inc.
ENSC	Ensysce Biosciences, Inc.
CMND	Clearmind Medicine Inc.